🚀 VC round data is live in beta, check it out!
Mersana Therapeutics Valuation Multiples
Discover revenue and EBITDA valuation multiples for Mersana Therapeutics and similar public comparables like Sangamo Therapeutics, Corbus Pharmaceuticals, vTv Therapeutics, Artiva Biotherapeutics and more.
Mersana Therapeutics Overview
Founded
N/A
HQ
—
Employees
102
Website
N/A
Sectors
Financials (FY)
EV
$91M
Mersana Therapeutics Stock Performance
Mersana Therapeutics has current market cap of $145M, and enterprise value of $91M.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $91M | $145M | — | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMersana Therapeutics Valuation Multiples
Mersana Therapeutics Financial Valuation Multiples
As of March 7, 2026, Mersana Therapeutics has market cap of $145M and EV of $91M.
Equity research analysts estimate Mersana Therapeutics' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $145M | XXX | $145M | XXX | XXX | XXX |
| EV (current) | $91M | XXX | $91M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Mersana Therapeutics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Mersana Therapeutics Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Sangamo Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Corbus Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| vTv Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Artiva Biotherapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Prestige Biologics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mersana Therapeutics M&A Activity
Mersana Therapeutics acquired XXX companies to date.
Last acquisition by Mersana Therapeutics was on XXXXXXXX, XXXXX. Mersana Therapeutics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Mersana Therapeutics
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMersana Therapeutics Investment Activity
Mersana Therapeutics invested in XXX companies to date.
Mersana Therapeutics made its latest investment on XXXXXXXX, XXXXX. Mersana Therapeutics invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Mersana Therapeutics
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Mersana Therapeutics
| How many employees does Mersana Therapeutics have? | As of today, Mersana Therapeutics has over 102 employees. |
| Is Mersana Therapeutics publicly listed? | Yes, Mersana Therapeutics is a public company listed on Nasdaq. |
| What is the stock symbol of Mersana Therapeutics? | Mersana Therapeutics trades under MRSN ticker. |
| When did Mersana Therapeutics go public? | Mersana Therapeutics went public in 2017. |
| Who are competitors of Mersana Therapeutics? | Mersana Therapeutics main competitors are Sangamo Therapeutics, Corbus Pharmaceuticals, vTv Therapeutics, Artiva Biotherapeutics. |
| What is the current market cap of Mersana Therapeutics? | Mersana Therapeutics' current market cap is $145M. |
| Is Mersana Therapeutics profitable? | No, Mersana Therapeutics is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.